Company attributes
Other attributes
Kiadis Pharma is a company that looks to provide options for stem cell transplant operations in blood cancer patients. The company was founded in 1997, in Amsterdam, Noord-Holland, The Netherlands.
The company is interested in creating solutions for patients that have complications and limitations due to blood cancer. They have created and developed three blood cancer products that are in clinical development that are meant to provide treatment options for terminal cancer patients.
Kladis Pharma is developing cancer immunotherapeutics as well as novel adjunctive treatments. In their pipeline they have an NK-cell Therapies for HSCT in blood cancer, AAML R/R, multiple myeloma, respiratory and COVID-19 diseases, and other cancers and infections. Their pipeline treatments are in phases one and two, as well as in proof-of-concept.
Their NK-cell Therapies (Natural Killer) are designed to assist the immune system's natural ability to detect, identify, and fight against diseases and malignant cancer cells.